Literature DB >> 24961631

Solid pseudopapillary tumor of the pancreas with liver metastasis: Clinical features and management.

Wei-Bin Wang1, Tai-Ping Zhang1, Meng-Qing Sun1, Zheng Peng1, Ge Chen1, Yu-Pei Zhao2.   

Abstract

OBJECTIVE: To summarize the diagnosis and management of metastatic pancreatic solid pseudopapillary tumors (SPTs).
METHODS: We retrospectively analyzed the clinical data of patients with metastatic pancreatic SPTs who were admitted to Peking Union Medical College Hospital from November 2001 to September 2013.
RESULTS: A total of 187 patients with pancreatic SPTs were admitted. Four patients had liver metastasis, and all four were female patients aged 20-72 years old. Each patient with metastases underwent surgical resection with good postoperative recovery. The mean follow-up period was 30 months (range, 1-64 months). None of the patients had obvious recurrence or distant metastasis.
CONCLUSIONS: Pancreatic SPT with liver metastasis is very rare, and surgical resection is an effective treatment option. The principle of surgical treatment is to resect the primary and metastatic lesions as completely as possible. The affected patients require long-term postoperative follow-up.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Liver metastasis; Pancreas; Pancreatic solid pseudopapillary tumor

Mesh:

Year:  2014        PMID: 24961631     DOI: 10.1016/j.ejso.2014.05.012

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  13 in total

1.  The prognosis and clinical characteristics of advanced (malignant) solid pseudopapillary neoplasm of the pancreas.

Authors:  Hongkai Zhang; Wenze Wang; Shuangni Yu; Yu Xiao; Jie Chen
Journal:  Tumour Biol       Date:  2015-11-11

2.  EGFR L861Q Mutation in a Metastatic Solid-pseudopapillary Neoplasm of the Pancreas.

Authors:  Kevin G Neill; James Saller; Sameer Al Diffalha; Barbara A Centeno; Mokenge P Malafa; Domenico Coppola
Journal:  Cancer Genomics Proteomics       Date:  2018 May-Jun       Impact factor: 4.069

Review 3.  Pancreatic Cystic Neoplasms: Different Types, Different Management, New Guidelines.

Authors:  Lianne Scholten; Nadine C M van Huijgevoort; Jeanin E van Hooft; Marc G Besselink; Marco Del Chiaro
Journal:  Visc Med       Date:  2018-06-08

4.  European evidence-based guidelines on pancreatic cystic neoplasms.

Authors: 
Journal:  Gut       Date:  2018-03-24       Impact factor: 23.059

5.  Solid pseudopapillary tumor of the pancreas: clinical-pathological features and management of 13 cases.

Authors:  Ovidiu Vasile Bochis; Madalina Bota; Emilia Mihut; Rares Buiga; Dan Samoila Hazbei; Alexandru Irimie
Journal:  Clujul Med       Date:  2017-04-25

6.  Features and Treatment of Peritoneal Metastases from Solid Pseudopapillary Neoplasms of the Pancreas.

Authors:  Jianhui Wu; Xiuyun Tian; Bonan Liu; Chengpeng Li; Chunyi Hao
Journal:  Med Sci Monit       Date:  2018-03-10

Review 7.  A Review of Clinicopathological Characteristics and Treatment of Solid Pseudopapillary Tumor of the Pancreas with 2450 Cases in Chinese Population.

Authors:  Jihang Yao; He Song
Journal:  Biomed Res Int       Date:  2020-07-01       Impact factor: 3.411

8.  Aggressiveness of solid pseudopapillary neoplasm of the pancreas: A literature review and meta-analysis.

Authors:  Emmanuel Ii Uy Hao; Ho Kyung Hwang; Dong-Sub Yoon; Woo Jung Lee; Chang Moo Kang
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

9.  Less Aggressive Surgical Procedure for Treatment of Solid Pseudopapillary Tumor: Limited Experience from a Single Institute.

Authors:  Chi Zhang; Fangfeng Liu; Hong Chang; Hongguang Li; Xu Zhou; Jun Lu; Chengkun Qin; Yongjie Sun; Huidong Sun; Jianbo Lin
Journal:  PLoS One       Date:  2015-11-23       Impact factor: 3.240

Review 10.  Prediction of malignancy and adverse outcome of solid pseudopapillary tumor of the pancreas.

Authors:  Li You; Feng Yang; De-Liang Fu
Journal:  World J Gastrointest Oncol       Date:  2018-07-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.